Document Security Systems, Inc. (DSS) News

Document Security Systems, Inc. (DSS): $1.88

0.07 (-3.35%)

POWR Rating

Component Grades

Momentum

C

Stability

D

Sentiment

Quality

F

Add DSS to Watchlist
Sign Up

Industry: Shipping

Industry

NR

Ranked

#45 of 45

in industry

Filter DSS News Items

DSS News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

DSS News Highlights

  • DSS's 30 day story count now stands at 3.
  • Over the past 24 days, the trend for DSS's stories per day has been choppy and unclear. It has oscillated between 1 and 2.
  • The most mentioned tickers in articles about DSS are DEC, NOV and PAR.

Latest DSS News From Around the Web

Below are the latest news stories about DSS INC that investors may wish to consider to help them evaluate DSS as an investment opportunity.

DSS, Inc. Announces Reverse Split as Part of NYSE American Compliance Plan

NEW YORK, Dec. 22, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS, “Company”), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, today announced that it will proceed with a 1-for-20 reverse stock split (the “Reverse Split”) of its issued and outstanding shares of common stock, par value $0.02, following authorization by its Board of Directors and majority

Yahoo | December 22, 2023

DSS: Q3 2023 Results Show Hesitation from DSS Customers Due to A Worsening Economy and Government Inaction

By Lisa Thompson NYSE:DSS READ THE FULL DSS RESEARCH REPORT DSS (NYSE:DSS) reported Q3 revenues of $4.2 million, down 65% from the year ago’s $11.9 million. Most of the total revenue decline was driven by a $4.4 million decline in Direct Marketing revenues as the company divested Sharing Global Services on May 4th. Direct marketing was down 89% year over year. On April 5th, Sharing was dividended

Yahoo | November 28, 2023

Premier Packaging, a Wholly-Owned Subsidiary of DSS, Inc., Secures Contract Extension with Major Retailer Worth Up to $15 Million over Four Years

Option for Fourth Year Brings Potential Revenue to Over $15 MillionNEW YORK, Nov. 28, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, announced today that its wholly-owned subsidiary, Premier Packaging, signed a contract extension with an existing client for the next three years totaling a minimum of $12

Yahoo | November 28, 2023

Impact Biomedical Inc. Files Current Report on Form 8-K

Biotechnology Company Currently in Initial Public Offering (IPO) ProcessNEW YORK, Nov. 15, 2023 (GLOBE NEWSWIRE) -- Impact Biomedical, Inc. (“the Company” and “Impact”) announced today that the Company filed a Current Report on Form 8-K with the Securities and Exchange Commission on November 6, 2023, disclosing that DSS BioHealth Security, Inc. (“DBH”), a subsidiary of DSS, Inc. (NYSE American: DSS), converted substantially all of its 87.5% common stock equity interest in Impact into an equivale

Yahoo | November 15, 2023

DSS Inc. Wins Patent Dispute with Nichia Corporation

NEW YORK, Nov. 14, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) announced today that, in a unan​i​mous decision, the Court of Appeals for the Federal Circuit (CAFC) rejected Nichia Corp.'s challenge to U.S. Patent No. 6,879,040 (the ‘040 Patent). U.S. Chief Circuit Judge Kimberly Moore, who authored the opinion, and U.S. Circuit Judges Kara Stoll and Tiffany Cunningham sat on the panel for the Federal Circuit. The CAFC appeal mounted by Nichia Corp., a Japanese electronics company, as

Yahoo | November 14, 2023

DSS, Inc. Subsidiary Files Current Report on Form 8-K Disclosing Reverse Split of Outstanding and Issued Common Stock and Conversion of Certain Holder’s Common Stock

DSS Shareholders to Benefit from Reduction in Common Stock of Impact BiomedicalNEW YORK, Nov. 08, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS) announced today that Impact BioMedical Inc. (“Impact”) filed a Current Report on Form 8-K with the Securities and Exchange Commission on November 6, 2023, disclosing that Impact effected a reverse stock split of its issued and outstanding common stock by a ratio of 1 for 55. Impact did not effectuate a reverse split of its authorized capital st

Yahoo | November 8, 2023

DSS Inc. Receives Notice of Non-Compliance with NYSE American Trading Share Price Listing Rule

Company intends to cure the deficiency and return to compliance with NYSE American standardNEW YORK, Oct. 26, 2023 (GLOBE NEWSWIRE) -- DSS, Inc.(NYSE American: DSS) announced today that the Company received a letter (the “Letter”) from the staff of NYSE American LLC (the “Exchange”) stating that the Company’s securities have been selling for a low price per share for a substantial period of time and, pursuant to Section 1003(f)(v) of the NYSE American Company Guide. The Company’s continued listi

Yahoo | October 26, 2023

DSS, Inc. Announces Filing of Registration Statement on Form S-1 for Initial Public Offering of Impact Biomedical

NEW YORK, Oct. 23, 2023 (GLOBE NEWSWIRE) -- DSS, Inc.(NYSE American: DSS) ("DSS") announced today that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange Commission ("SEC") relating to the proposed initial public offering of the Company's wholly-owned subsidiary, Impact Biomedical (hyperlink: https://www.impactbiomedinc.com/). DSS, Inc. intends to list Impact Biomedical on the NYSE American exchange. The number of shares of Class A common stock to be offered

Yahoo | October 23, 2023

DSS Inc. Issues Letter to Shareholders

CEO Highlights Expected IPO of Impact Biomedical and Progress in SubsidiariesROCHESTER, N.Y., Oct. 12, 2023 (GLOBE NEWSWIRE) -- DSS, Inc. (NYSE American: DSS), a multinational company operating nine (9) diversified business lines developed through strategic acquisitions to build shareholder value through periodic spinoffs to its shareholders, announced today that it has issued a Letter to Shareholders. Dear Valued Shareholders, On behalf of the management team at DSS, Inc., I am pleased to provi

Yahoo | October 12, 2023

DSS Inc. Expands DSS Wealth Management, Inc.'s Management Team for Ramp Up of Asset Management Subsidiary

Jim Monaghan Appointed Chief Operating Officer and Chief Compliance Officer; Michael Cheah Joins as Portfolio Manager and Head of Fixed IncomeROCHESTER, N.Y., Sept. 06, 2023 (GLOBE NEWSWIRE) -- DSS Wealth Management, Inc., a wholly owned subsidiary of DSS, Inc. and advisor to DSS AmericaFirst Quantitative Funds, is pleased to announce that Jim Monaghan has joined as Chief Operating Officer and Chief Compliance Officer and Michael Cheah has joined DSS Wealth Management in the role of Portfolio Ma

Yahoo | September 6, 2023


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!